
Algeclo SP Tablet
Marketer
Algen Healthcare Limited
Salt Composition
Aceclofenac (100mg) + Paracetamol (325mg) + Serratiopeptidase (15mg)
Overview Algeclo SP Tablet
Combiflam SR tablets combine medications to address pain and inflammation in conditions such as muscular aches, arthritic joints, and post-surgical discomfort. This effectively manages symptoms in rheumatoid arthritis, ankylosing spondylitis, and osteoarthritis. Dosage and duration should strictly follow your physician's instructions. Administer with food or milk to minimize stomach irritation. Consistent, timely medication use maximizes therapeutic benefit. Continue treatment as prescribed until medically advised to discontinue. Potential side effects include nausea, vomiting, abdominal pain, dyspepsia, heartburn, elevated liver enzymes, vertigo, somnolence, and diarrhea. Your doctor may monitor kidney and liver function, and blood counts, particularly during prolonged therapy. Extended use carries risks of gastrointestinal bleeding and renal complications. This medication is contraindicated during pregnancy and lactation.
Uses of Algeclo SP Tablet
Analgesia
Major Benefits of Algeclo SP Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Algeclo SP Tablet should be administered with a meal.
Common Side effects of Algeclo SP Tablet:
- Nausea
- Vomiting
- Stomach pain
- Indigestion
- Heartburn
- Loss of appetite
- Diarrhea
- Dizziness
- Increased liver enzymes
- Drowsiness
How to use Algeclo SP Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for Algeclo SP Tablet. Ingest the tablet whole; do not chew, crush, or divide it. Always take it with food.
How Algeclo SP Tablet works:
Algeclo SP Tablet unites Aceclofenac, Paracetamol, and Serratiopeptidase to alleviate pain and inflammation. Aceclofenac, a non-steroidal anti-inflammatory drug (NSAID), and the analgesic Paracetamol, reduce pain and fever by inhibiting the production of inflammatory mediators in the central nervous system. Serratiopeptidase, a proteolytic enzyme, aids healing by degrading abnormal proteins within inflamed tissues.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Algeclo SP Tablet is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Using Algeclo SP Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against possible hazards prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on Algeclo SP Tablet use while breastfeeding is lacking. Seek your physician's advice.
DrivingUNSAFE
Taking Algeclo SP Tablets might reduce attentiveness, impair vision, or cause drowsiness and dizziness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
Patients with kidney impairment should use Algeclo SP Tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. Algeclo SP Tablets are contraindicated in individuals with severe kidney disease.
LiverCAUTION
Patients with liver impairment should use Algeclo SP Tablet cautiously, potentially requiring dosage modification under medical supervision. Its use is contraindicated in those with severe or active liver disease.
What if you forget to take Algeclo SP Tablet :
Should you forget to take Algeclo SP Tablet, ingest it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Algeclo SP Tablet
| Label | Value |
|---|---|
| Addictive | None. |
| Medication Classification | Pain relievers |
